Upon recommendation of the Nominating and Governance Committee of the Board of Directors of Bionano Genomics, Inc. (the Company), on February 17, 2022, the Board appointed Aleksandar Rajkovic as a Class III director, effective as of such date, to serve in such capacity until the Company's 2024 annual meeting of stockholders. Dr. Rajkovic will receive compensation for his service as a director in accordance with the Company's Non-Employee Director Compensation Policy, as amended (the Compensation Policy).